216 related articles for article (PubMed ID: 34050547)
1. Design, synthesis, and molecular docking study of novel quinoline-based bis-chalcones as potential antitumor agents.
Insuasty D; García S; Abonia R; Insuasty B; Quiroga J; Nogueras M; Cobo J; Borosky GL; Laali KK
Arch Pharm (Weinheim); 2021 Sep; 354(9):e2100094. PubMed ID: 34050547
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, characterization, and anticancer activity of a novel series of O-substituted chalcone derivatives.
Ngameni B; Cedric K; Mbaveng AT; Erdoğan M; Simo I; Kuete V; Daştan A
Bioorg Med Chem Lett; 2021 Mar; 35():127827. PubMed ID: 33508467
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, and Anticancer Activity Studies of Novel Quinoline-Chalcone Derivatives.
Guan YF; Liu XJ; Yuan XY; Liu WB; Li YR; Yu GX; Tian XY; Zhang YB; Song J; Li W; Zhang SY
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443487
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel quinoline-2-one based chalcones of potential anti-tumor activity.
Abonia R; Insuasty D; Castillo J; Insuasty B; Quiroga J; Nogueras M; Cobo J
Eur J Med Chem; 2012 Nov; 57():29-40. PubMed ID: 23043766
[TBL] [Abstract][Full Text] [Related]
5. New quinoline/chalcone hybrids as anti-cancer agents: Design, synthesis, and evaluations of cytotoxicity and PI3K inhibitory activity.
Abbas SH; Abd El-Hafeez AA; Shoman ME; Montano MM; Hassan HA
Bioorg Chem; 2019 Feb; 82():360-377. PubMed ID: 30428415
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, Cytotoxicity Evaluation, Molecular Docking and Utility of Novel Chalcones as Precursors for Heterocycles Incorporating Pyrazole Moiety.
Gomha SM; Abdallah MA; Abbas IM; Kazem MSH
Med Chem; 2018; 14(4):344-355. PubMed ID: 29065841
[TBL] [Abstract][Full Text] [Related]
7. Novel p-Functionalized Chromen-4-on-3-yl Chalcones Bearing Astonishing Boronic Acid Moiety as MDM2 Inhibitor: Synthesis, Cytotoxic Evaluation and Simulation Studies.
Bhatia RK; Singh L; Garg R; Kaur M; Yadav M; Madan J; Kancherla S; Pissurlenkar RRS; Coutinho EC
Med Chem; 2020; 16(2):212-228. PubMed ID: 31146672
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and docking study of new quinoline derivatives as antitumor agents.
Nasr EE; Mostafa AS; El-Sayed MAA; Massoud MAM
Arch Pharm (Weinheim); 2019 Jul; 352(7):e1800355. PubMed ID: 31081954
[TBL] [Abstract][Full Text] [Related]
9. Identification of quinoline-chalcones and heterocyclic chalcone-appended quinolines as broad-spectrum pharmacological agents.
Atukuri D; S V; R S; L V; R P; M M R
Bioorg Chem; 2020 Dec; 105():104419. PubMed ID: 33142228
[TBL] [Abstract][Full Text] [Related]
10. Imidazopyridine chalcones as potent anticancer agents: Synthesis, single-crystal X-ray, docking, DFT and SAR studies.
Soumyashree DK; Reddy DS; Nagarajaiah H; Naik L; Savanur HM; Shilpa CD; Sunitha Kumari M; Shanavaz H; Padmashali B
Arch Pharm (Weinheim); 2023 Jul; 356(7):e2300106. PubMed ID: 37208792
[TBL] [Abstract][Full Text] [Related]
11. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer.
Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA
Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel pyrazolic analogues of chalcones and their 3-aryl-4-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)-1-phenyl-1H-pyrazole derivatives as potential antitumor agents.
Insuasty B; Tigreros A; Orozco F; Quiroga J; Abonía R; Nogueras M; Sanchez A; Cobo J
Bioorg Med Chem; 2010 Jul; 18(14):4965-74. PubMed ID: 20594863
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of New 1,3,5-Triazine-Based 2-Pyrazolines as Potential Anticancer Agents.
Moreno LM; Quiroga J; Abonia R; Ramírez-Prada J; Insuasty B
Molecules; 2018 Aug; 23(8):. PubMed ID: 30082588
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Cytotoxic Activities of Difluoro-Dimethoxy Chalcones.
Yamali C; Gul HI; Ozgun DO; Sakagam H; Umemura N; Kazaz C; Gul M
Anticancer Agents Med Chem; 2017; 17(10):1426-1433. PubMed ID: 28356013
[TBL] [Abstract][Full Text] [Related]
15. New chalcone-sulfonamide hybrids exhibiting anticancer and antituberculosis activity.
Castaño LF; Cuartas V; Bernal A; Insuasty A; Guzman J; Vidal O; Rubio V; Puerto G; Lukáč P; Vimberg V; Balíková-Novtoná G; Vannucci L; Janata J; Quiroga J; Abonia R; Nogueras M; Cobo J; Insuasty B
Eur J Med Chem; 2019 Aug; 176():50-60. PubMed ID: 31096118
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation and molecular docking studies of a new series of chalcones containing naphthalene moiety as anticancer agents.
Wang G; Qiu J; Xiao X; Cao A; Zhou F
Bioorg Chem; 2018 Feb; 76():249-257. PubMed ID: 29197743
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anticancer evaluation of certain 4-anilinofuro[2,3-b]quinoline and 4-anilinofuro[3,2-c]quinoline derivatives.
Chen YL; Chen IL; Wang TC; Han CH; Tzeng CC
Eur J Med Chem; 2005 Sep; 40(9):928-34. PubMed ID: 15913847
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of a novel series of chalcones incorporated pyrazole moiety as anticancer and antimicrobial agents.
Mohamed MF; Mohamed MS; Shouman SA; Fathi MM; Abdelhamid IA
Appl Biochem Biotechnol; 2012 Nov; 168(5):1153-62. PubMed ID: 22948604
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel quinoline-based 4,5-dihydro-1H-pyrazoles as potential anticancer, antifungal, antibacterial and antiprotozoal agents.
Ramírez-Prada J; Robledo SM; Vélez ID; Crespo MDP; Quiroga J; Abonia R; Montoya A; Svetaz L; Zacchino S; Insuasty B
Eur J Med Chem; 2017 May; 131():237-254. PubMed ID: 28329730
[TBL] [Abstract][Full Text] [Related]
20. Pyrazole-coumarin and pyrazole-quinoline chalcones as potential antitubercular agents.
Kumar G; Siva Krishna V; Sriram D; Jachak SM
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000077. PubMed ID: 32484273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]